EU-Startups
UK’s Nuclera brings Series C funding to €74 million following €10 million extension for its eProtein Discovery system
Cambridge-based Nuclera, a BioTech company accelerating drug discovery by providing access to functional proteins through its benchtop eProtein Discovery System, today announced a €10 million ($12 […]
